Implications of epidermal growth factor (EGF) induced egf receptor aggregation  by Wofsy, C. et al.
Implications of epidermal growth factor (EGF) induced egf
receptor aggregation
Carla Wofsy,* Byron Goldstein,* Kirk Lund,§ and H. Steven Wiley§
*Department of Mathematics and Statistics, University of New Mexico, Albuquerque, New Mexico 87131; *Theoretical Biology and
Biophysics Group, Theoretical Division, T-10, MS K710, Los Alamos National Laboratory, Los Alamos, New Mexico 87545; §Division
of Immunology and Cell Biology, Department of Pathology, Center for the Health Sciences, University of Utah, Salt Lake City, Utah 84132
ABSTRACT To investigate the role of receptor aggregation in EGF binding, we construct a mathematical model describing receptor
dimerization (and higher levels of aggregation) that permits an analysis of the influence of receptor aggregation on ligand binding. We
answer two questions: (a) Can Scatchard plots of EGF binding data be analyzed productively in terms of two noninteracting receptor
populations with different affinities if EGF induced receptor aggregation occurs? No. If two affinities characterize aggregated and
monomeric EGF receptors, we show that the Scatchard plot should have curvature characteristic of positively cooperative binding, the
opposite of that observed. Thus, the interpretation that the high affinity population represents aggregated receptors and the low affinity
population nonaggregated receptors is wrong. If the two populations are interpreted without reference to receptor aggregation, an
important determinant of Scatchard plot shape is ignored. (b) Can a model for EGF receptor aggregation and EGF binding be consistent
with the 'negative curvature" (i.e., curvature characteristic of negatively cooperative binding) observed in most Scatchard plots of EGF
binding data? Yes. In addition, the restrictions on the model parameters required to obtain negatively curved Scatchard plots provide
new information about binding and aggregation. In particular, EGF binding to aggregated receptors must be negatively cooperative, i.e.,
binding to a receptor in a dimer (or higher oligomer) having one receptor already bound occurs with lower affinity than the initial binding
event. A third question we consider is whether the model we present can be used to detect the presence of mechanisms other than
receptor aggregation that are contributing to Scatchard plot curvature. For the membrane and cell binding data we analyzed, the best
least squares fits of the model to each of the four data sets deviate systematically from the data, indicating that additional factors are also
important in shaping the binding curves. Because we have controlled experimentally for many sources of receptor heterogeneity, we
have limited the potential explanations for residual Scatchard plot curvature.
INTRODUCTION
Ligand induced receptor clustering is a phenomenon
common to many receptor systems. Ligands with va-
lence greater than one, of the appropriate size and flexi-
bility, can aggregate receptors by cross-linking them, i.e.,
bridging two or more receptors. Multivalent antigens ag-
gregate cell surface immunoglobulin (Schreiner and Un-
anue, 1976), IgG-containing immune complexes aggre-
gate FcRII receptors (Unkeless et al., 1981), and bivalent
platelet-derived growth factor (PDGF) clusters PDGF
receptors (Heldin et al., 1989). Although monovalent li-
gands are incapable of crosslinking receptors, some
monovalent ligands, such as interleukin 2 (IL-2) (Ha-
takeyama et al., 1989) and epidermal growth factor
(EGF) (Yarden and Schlessinger, 1987b), induce recep-
tor clustering. Presumably, occupation of the receptor
binding site by these ligands affects one or more extracel-
lular domains responsible for receptor clustering, i.e.,
these ligands modulate receptor clustering by allosteric
mechanisms.
Whenever ligands aggregate receptors the question
arises as to what role receptor aggregation plays in trans-
duction of signals across the plasma membrane. For
some receptor systems it is clear that receptor aggrega-
tion is necessary for cell signaling. For example, monova-
lent ligands that bind to IgE on sensitized basophils and
mast cells trigger no cellular responses (Siraganian et al.,
1975), while multivalent ligands that aggregate IgE trig-
ger a host ofresponses (reviewed in Metzger et al., 1986).
For other receptor systems the necessity of receptor ag-
gregation for the generation of transmembrane signals
has not been demonstrated. Two IL-2 receptors have
been isolated, a p55 and p75 chain that bind IL-2 with
low and intermediate affinities respectively. These recep-
tors cluster into p55-p75 heterodimers that bind IL-2
with high affinity (reviewed in Smith, 1989). The pres-
ence ofp55-p75 heterodimers allows cells to bind IL-2 at
pM rather than nM concentrations, suggesting that an
important function ofp55-p75 heterodimer formation is
to increase the cell's sensitivity to IL-2. However, a
unique signal function for the p55-p75 heterodimer has
not been identified.
The binding ofepidermal growth factor (EGF) to solu-
bilized EGF receptors causes these receptors to dimer-
ize rapidly (Yarden and Schlessinger, 1987b; Boni-
Schnetzler and Pilch, 1987; Cochet et al., 1988; Fanger et
al., 1989). The soluble, extracellular, EGF-binding do-
main is sufficient for receptor aggregation (Lax et al.,
1991). Fluorescence resonance energy transfer studies of
EGF receptors in membranes isolated from A431 cells
indicate enhanced dimerization in the presence ofEGF
and divalent metal ion activators (Carraway III et al.,
1989), but the method does not detect EGF induced di-
merization on intact A431 cells (Carraway III and Cer-
ione, 1991). EGF induced receptor dimerization has
been detected in chemical cross-linking studies both on
isolated plasma membranes (Cochet et al., 1988; North-
wood and Davis, 1 988a, b) and on intact cells (Fanger et
al., 1986; Cochet et al., 1988; Northwood and Davis,
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1988b; Sorkin and Carpenter, 1991). Higher oligomers
of EGF receptors have also been detected on isolated
membranes (Northwood and Davis, 1988a) and in solu-
tion (Lax et al., 1991). On A431 cells dimerization is
considerably reduced in the absence of EGF, but still
detectable by chemical crosslinking (Cochet et al., 1988).
However, fluorescence resonance energy transfer studies
failed to observe EGF induced dimerization on A431
cells, even though the method detected significant dimer-
ization on purified plasma membranes and membranes
from disrupted cells (Carraway III and Cerione, 1991).
The mature EGF receptor is a single polypeptide chain
of 1,186 amino acid residues possessing an extracellular
EGF binding domain, a single membrane spanning re-
gion and an intracellular protein tyrosine kinase do-
main. Binding ofEGF to the external portion ofthe EGF
receptor activates the internal protein tyrosine kinase
domain, leading to increased substrate phosphorylation
and auto-phosphorylation of receptor tyrosine residues
(reviewed in Carpenter, 1987).
Two classes of models have been proposed to explain
how the binding ofEGF to the extracellular binding do-
main of the receptor activates the cytoplasmic kinase
domain. In one class of models, activation occurs
through an intramolecular mechanism (Staros et al.,
1985; Koland and Cerione, 1988). Binding of EGF is
conjectured to induce a conformational change in the
receptor which is transmitted through the transmem-
brane domain and activates intrinsic receptor protein
tyrosine kinase activity (Bertics and Gill, 1985; Weber et
al., 1984). In the other class ofmodels, activation is con-
trolled by receptor aggregation (Schlessinger, 1986;
1988; Yarden and Schlessinger, 1987a). In these models,
the binding of EGF to monomeric receptors enhances
receptor aggregation. The aggregated receptors have
higher affinity for EGF than the unaggregated receptors
and possess elevated protein tyrosine kinase activity.
Both models are supported by experimental data. Be-
cause activation of tyrosine kinase by EGF has been
observed for monomeric EGF receptors that are either
detergent-solubilized (Koland and Cerione, 1988) or
membrane bound (Northwood and Davis, 1988a), ag-
gregation cannot be an absolute requirement for recep-
tor activation. However, because cross-linking EGF re-
ceptors with bivalent antibodies stimulates receptor tyro-
sine kinase while exposure to Fab fragments does not
(Spaargaren et al., 1991), aggregation is clearly sufficient
to activate the receptor. Also, Honegger et al. (1989)
showed that in a solution of two mutant receptors, one
lacking and the other possessing kinase activity, the re-
ceptor lacking kinase activity was phosphorylated and
phosphorylation was dependent on EGF. Thus, this
"auto"-phosphorylation of solubilized mutant EGF re-
ceptors was mediated by intermolecular interactions.
Honegger et al. (1989) proposed that phosphorylation
was facilitated by EGF receptor oligomerization and
they were able to isolate oligomers that contained both
types of mutant EGF receptors.
A major component of the dimerization-activation
hypothesis is that the affinity of EGF for aggregated re-
ceptors is higher than for monomeric receptors (Boni-
Schnetzler and Pilch, 1987; Yarden and Schlessinger,
1987a; Northwood and Davis, 1988a). This was postu-
lated to explain why a high affinity subclass of receptors
appears dominant in mediating signal transduction and
biological responses (Yarden and Schlessinger, 1987a;
Defize et al., 1989; Bellot et al., 1990). The high affinity
subclass has been proposed to represent the aggregated,
active fraction of the receptor population (Schlessinger,
1988). Despite the evidence for EGF receptor dimer for-
mation, its effect on EGF binding, and the related effect
of EGF binding on receptor dimerization, published
analyses of EGF binding data are based on models that
do not include receptor aggregation. When EGF binds to
EGF receptors, Scatchard plots usually show negative
curvature, i.e., curvature associated with negatively coop-
erative binding. One way such curvature can arise other
than by negative cooperativity is if there is heterogeneity
in the binding affinities of the receptors. For this reason
much of the published EGF binding data has been ana-
lyzed in terms oftwo populations of receptors, one with
high and one with low affinity for EGF. Often, the im-
plicit interpretation of the two populations is that one is
a low affinity population of monomeric receptors and
the other a high affinity population of receptors in
dimers or higher oligomers. We will show that this inter-
pretation is incorrect, because such a model predicts that
a Scatchard plot will have curvature characteristic ofpos-
itive cooperativity, the opposite of what is seen experi-
mentally.
In this paper we develop a model for EGF receptor
aggregation and binding, and use it to analyze equilib-
rium binding data. Through the model we investigate
the implications of the three observations we have dis-
cussed concerning EGF receptor aggregation and EGF-
EGF receptor binding: (a) EGF receptors self aggregate,
i.e., in the absence ofEGF there are some EGF receptor
oligomers on the cell surface; (b) the addition of EGF
increases the concentration of EGF receptors in oligo-
mers; and (c) Scatchard plots for EGF binding to EGF
receptors that are in solution, on closed vesicles or on cell
surfaces do not exhibit positive cooperativity. We show
that for these three results to be consistent with each
other, either binding to oligomers must be negatively co-
operative (i.e., the equilibrium constant for EGF binding
to a single EGF receptor in a dimer must be higher when
both sites are free than when only one site is free), or
there must be significant contributions to the curvature
in the Scatchard plot from sources other than genetic
heterogeneity in the EGF receptor population, interac-
tions with the cytoskeleton, or receptor-mediated endo-
cytosis. These latter possibilities we eliminate by carry-
ing out binding studies on closed membrane vesicles de-
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rived from cells that normally express no EGF receptors
and that have been transfected with either wild-type or
mutant human EGF receptor cDNAs.
MATERIALS AND METHODS
General
Mouse EGF was purified from submaxillary glands (Savage and Co-
hen, 1972). EGF was iodinated with 1251 (Amersham Corp., Arlington
Heights, IL) using lodo-Beads (Pierce Chemical Co., Rockford, IL)
according to the manufacturer's recommendations and free iodine sep-
arated from the radiolabeled ligands by dialysis or by passing the mix-
ture over a 0.8 X 20 cm column of Sephadex G-10 equilibrated with
PBS. The specific activity of '25I-labeled EGF was generally between
600 and 1,800 cpm/fmol. Protein concentration was determined using
the BCA assay (Pierce Chemical Co.) and using bovine serum albumin
as a standard.
Cell culture
B82 mouse L cells, which contain no endogenous EGF receptors, and
B82 cells transfected with wild type or mutated (M721, A654M72Ic'1022,
c' 1022, and M72Ic' 1022) human EGF receptors were generated as previ-
ously described (Chen et al., 1989). A modified dihydrofolate reductase
gene was the selectable marker for all transfections. B82 cells were
grown in Dulbecco's modified Eagle's medium (DME, Flow Laborato-
ries, Inc., McClean, VA) containing dialyzed 10% calf serum (Hy-
Clone). 5 MM methotrexate was added to the medium for those cells
transfected with human EGF receptor.
Isolation of plasma membrane vesicles
Cells were grown to confluence in roller bottles. After rinsing four times
with phosphate-buffered saline lacking Ca2' and Mg2' at 0°C, the cells
were removed using a rubber policeman and pelleted at 600 g for 1
min. The cell pellet was weighed, followed by the addition ofa 20-fold
volume of homogenization buffer consisting of 10 mM Tris-Cl (pH
8.0), 2 mM EDTA and 10 ,g/ml each ofthe protease inhibitors leupep-
tin, chymostatin and pepstatin. The cells were allowed to swell 5 min
on ice and then homogenized with 10 strokes of a tight-fitting dounce
homogenizer. Cell breakage was monitored by phase-contrast micros-
copy and was >90%. The homogenate was brought to 1 mM MgCl2,
1.5 mM CaCl2 and the nuclei were removed by centrifugation for 2 min
at 1,000 g. The postnuclear supernatant (12 ml) was loaded on a su-
crose step gradient consisting of 7 ml 50% sucrose and 15 ml 30%
sucrose and centrifuged for 20 min at 10,000 rpm in an SW28 rotor at
4°C. Membranes at the 30-50% interface were collected, resuspended
in 4 volumes of homogenization buffer and pelleted by centrifugation
at 7,000 g for 5 min. The vesicles were resuspended to a final concen-
tration of 1-2 mg/ml using a dounce homogenizer.
Binding to intact cells
Cells grown to confluence in 35 mm dishes were switched from growth
medium to serum freeDME containing 20mM HEPES (pH 7.4), 0.1%
BSA and no bicarbonate (D/H/B) 18 h before experiments. Cells were
rapidly chilled to 0°C by rinsing twice with ice-cold WHIPS saline (20
mM HEPES, pH 7.4, 130 mM NaCl, 5 mM KCI, 0.5 mM MgCl2, 1
mM CaCI2, 1 mg/ml poly-vinylpyrrolidone) and cold D/H/B medium
containing '251-EGF was added. Concentrations of '251-EGF ranged
between 0.05-170 nM. The cells were allowed to reach equilibrium at
0°C (4-6 hrs), aliquots ofthe medium were taken for determination of
free ligand concentration, and the cells were rinsed six times with cold
WHIPS saline. Receptor-associated ligand was then removed by acid-
stripping at 0°C using 50 mM glycine-HCl, 100 mM NaCl, 2 mg/ml
PVP, 2 M Urea, pH 3.0, and then counted in agamma spectrophotome-
ter. Nonspecific binding was determined by parallel binding studies
using B82 cells lacking EGF receptors and was always less than 5% of
total binding. Cell number was determined with a Coulter Counter.
Binding to membranes
Membrane concentrations were adjusted to between 1-2 mg/ml pro-
tein in 100 mM Hepes buffer, pH. 7.0. A 40 ul aliquot of membranes
was added to 100 ,ul of 100 mM Hepes, 1 mg/ml BSA containing 125[I
EGF at concentrations ranging between 0.15-40 nM in microfuge
tubes. The tubes were capped, mixed and then brought to equilibrium
for 4 h at 22°C on a shaker platform. To each individual tube was
added 1 ml of ice-cold WHIPS saline containing 1 mg/ml of bovine
serum albumin (WHIPS/BSA) immediately followed by collection of
the membranes on millipore GVWP 025 filters using a filtration mani-
fold. The tubes and filters were rinsed 3 times with cold WHIPS/BSA.
After air drying, the filters were counted in a gamma spectrophotome-
ter. Nonspecific binding was determined by parallel binding studies
using membranes isolated from B82 cells lacking EGF receptors.
Data analysis
Parameter estimation was carried out using a nonlinear least squares
fitting routine ZXSSQ, from the International Mathematics and Statis-
tics Library (IMSL). The routine is based on a finite difference, Leven-
berg-Marquardt algorithm.
THE MODEL AND THEORETICAL RESULTS
We construct the simplest equilibrium model that in-
cludes EGF receptor aggregation and EGF binding.
Then we determine restrictions on the parameters im-
posed by the following experimental observations: (a)
The EGF receptor forms dimers in the absence of EGF;
(b) EGF receptor aggregation is enhanced in the presence
ofEGF; and (c) Scatchard plots for the equilibrium bind-
ing ofEGF to EGF receptors show no positive coopera-
tivity. (Derivations of the conditions we obtain are in-
cluded in the Appendix.)
Because we consider an equilibrium model where
there is no internalization of EGF receptors, the theory
we present is applicable only to EGF receptors in solu-
tion, on cell membrane fragments, on vesicles, and on
cells where internalization is blocked. Further, we con-
sider only the case where EGF receptors are genetically
homogeneous and where protein kinase C does not act
on the EGF receptor to alter its affinity, thereby intro-
ducing heterogeneity in receptor affinity. Finally, we as-
sume that only EGF receptor dimers can form. The
dimer model we arrive at is that first proposed by Le-
vitzki and Schlessinger (1974). In the Appendix we show
how the model can be generalized to include higher oligo-
mers and discuss the questions that arise when this is
attempted.
Fig. 1 illustrates the binding and aggregation reactions
that can occur in the model. We define six equilibrium
constants: three equilibrium binding constants, K, K1
and K2 that characterize respectively the binding ofEGF
to an isolated receptor, to a receptor in a dimer where
both binding sites are free, and to a receptor in a dimer
where one site is free and one bound; and three equilib-
rium aggregation constants, K, KX1 and KX2 that charac-
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FIGURE 1 Shown are the binding and aggregation reactions that can
occur when aggregation is restricted to dimer formation.
terize respectively the aggregation of two free receptors,
one bound and one free receptor, and two bound recep-
tors. (Note that the K's have units ofvolume whereas the
Kx's have units ofvolume when the receptors are in solu-
tion and units of area when the receptors are on mem-
branes.) Of the six equilibrium constants only four are
independent. From detailed balance we have:
KXl = KxKC/K
KX2 = KXKIKJK2.
(1)
(2)
In deriving Eqs. 1 and 2 we have assumed that the state
ofan aggregate is independent ofthe way in which it was
formed. For example, Eq. 1 follows if a dimer with one
site free and one bound is the same whether it is formed
by an EGF molecule binding to a dimer with both sites
free or by a free EGF receptor aggregating with a bound
EGF receptor.
To be consistent with experimental observation 1, that
EGF receptors aggregate in the absence ofEGF, we sim-
ply require that
KX °. (3)
The second experimental observation is that the pres-
ence ofEGF increases EGF receptor aggregation. For the
model to be consistent with experiment, at a minimum it
must have the property that the addition ofEGF leads to
an initial increase in receptor aggregation, i.e., in a plot
of oligomerization versus EGF concentration the initial
slope must be positive. For this to occur we must have
Kxl > KX and therefore, from Eq. 1,
K, > K.
mers is greater in the presence of a large excess of EGF
than in the absence of EGF, Fig. 2, a and b, then
Kw2> K.. This is because when there is a large amount of
EGF present, at equilibrium almost all EGF receptors
have bound EGF. Thus, at high EGF concentrations
dimer formation takes place between EGF receptors that
have bound EGF, and this is characterized by the aggre-
gation constant KX2 (see Fig. 1). We note that from Eq. 2
the condition KX2> KX implies that K1K2> K2. In sum-
mary, both curves in Fig. 2, a and b, obey the conditions
that K1 > K and K1K2> K2. In addition to these condi-
tions, in order for the curve to be monotonically increas-
ing, Fig. 2 a, K2> K, whereas in Fig. 2 b we have that
K2 < K. In Fig. 2 c, where the initial slope is positive, but
there are fewer dimers at very high EGF concentrations
than in the absence of EGF, we have, as before, K1 > K,
but K1K2 < K2.
In the absence of EGF the fraction of receptors in
dimers, do, is
=
2KXRT + 1- 1+ 4KXRT
2KXRT (5)
where RT is the concentration of EGF receptors. Eq. 5
can be used to determine K., but this requires that both
the concentration of EGF receptors and the fraction of
these receptors in dimers in the absence ofEGF be accu-
rately determined.
It is useful to define the dimensionless lumped parame-
ter,
kX = KXRT, (6)
because it is this parameter that determines what frac-
tion of the EGF receptors are in dimers in the absence of
EGF. For example, when kx = 1, do = 0.38, i.e., 38% of
all EGF receptors are in dimers in the absence of EGF.
Thus, in the absence of EGF, there is substantial dimer-
ization when kx > 1 and negligible dimerization when
kX< 1. (When k, it follows from Eq. 5 that do k,.)
C
0
C.)
a)
(4)
In Fig. 2 we show three different ways in which oligomer-
ization could depend on the EGF concentration and in-
crease initially with the addition ofEGF. The concentra-
tion ofEGF receptors in aggregates could be a monoton-
ically increasing function ofthe EGF concentration, or it
could increase initially to a maximum and then decline
to a final value that is either greater than or less than its
value in the absence ofEGF. Ifthe concentration ofoligo-
o
10-6 100 106 10-6 100 106 10-6 1o0 106
KC
FIGURE 2 Shown are three possible ways in which dimer formation
can depend on the free EGF concentration. The fraction ofEGF recep-
tors in dimers is plotted against the free EGF concentration. For each of
the curves shown, K,RT = 0.5 and K1/K = 100. The values of the
parameter KJK were (a) 10, (b) 0.1 and (c) 0.001.
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Finally, for our model to be consistent with experimen-
tal observation c, i.e., that the Scatchard plot shows no
positive cooperativity, the following condition between
the equilibrium binding and aggregation constants must
be obeyed:
0 5.0 0 5.0 0 5.0
al=KI/K
FIGURE 4 We require that our model predict the following: (1) that
there be some EGF receptors in dimers in the absence of EGF; (2) at
low EGF concentrations, the addition ofEGF increases the concentra-
tion of EGF receptors in dimers; and (3) that Scatchard plots for EGF
binding to EGF receptors do not show positive cooperativity. This
places restrictions on the values ofthe parameters in the model. This is
illustrated for the case when KXRT = 0.1, which corresponds to having
8% of the EGF receptors in dimers in the absence of EGF (see Eq. 5).
The shaded areas in the plots show the three parameter sets leading to
the three types of dimerization curve shown in Fig. 2. In the above
figures, the monotonically increasing curve is Eq. 7 when equality
holds. Then all of the shaded regions correspond to parameters satisfy-
ing the inequality given by Eq. 7, i.e., the condition under which a
Scatchard plot does not indicate positive cooperativity. In addition, all
of the shaded regions have K, > K, the condition for an initial increase
in the fraction of EGF receptors in dimers, as the EGF concentration
increases from 0. The monotonically decreasing curve is K2= K1K2. In
Fig. 4 a, the shaded region has K2 > K. In Fig. 4 b, the shaded region has
K1K2 > K2 and K2 < K. In Fig. 4 c, the shaded region has K1K2 < K2.
satisfied simultaneously. The restrictions this places on
the parameters are illustrated in Fig. 4, a, b, and c, which
correspond to the three possible ways in which dimer
formation can depend on EGF concentration (see Fig.
2). In Fig. 4 the shaded areas correspond to the values of
K1 and K2 that are allowable (consistent with experi-
ment). If dimerization increases monotonically with
EGF concentration, as shown for EGF receptors purified
from A431 cells (Yarden and Schlessinger, 1987b) and
EGF receptors on A43 1 cell membranes (Carraway III
and Cerione, 1991), the parameters must fall within the
shaded area of Fig. 4 a.
EXPERIMENTAL RESULTS
To focus on the effect of receptor aggregation on EGF
binding data, we studied the equilibrium binding ofEGF
to receptors on closed membranes derived from B82
cells transfected with the human EGF receptor (Chen et
al., 1987). The use of membranes eliminated the effects
of internalization and cytoskeletal interactions on the
EGF binding curves obtained. Because B82 cells lack
endogenous EGF receptors and because we are transfect-
ing with only a single receptor genotype for each set of
binding studies, heterogeneity in primary receptor struc-
ture is eliminated. Membranes were isolated from cells
expressing wild type and three mutant receptors. The
II
(.4
I,
(7)
Because the right side ofthis inequality is positive the left
side must also be. Therefore it is necessary, but not suffi-
cient, that
K, > K2. (8)
This means that binding to dimers must exhibit negative
cooperativity, i.e., the affinity for EGF binding to a sin-
gle EGF receptor in a dimer when both binding sites are
free must be greater than when only one site is free. This
asymmetry in the binding properties of the dimer arises
even though in the absence ofEGF all EGF receptors are
identical. One way that this could occur is through steric
hindrance. The binding of EGF to one site on a dimer
could partially block the second site. Another possibility
is that the binding of EGF to one receptor in a dimer
leads to alteration ofthe binding properties ofthe second
receptor through an intermolecular mechanism. In Fig.
3 we illustrate that when K1 = K2 the model predicts a
Scatchard plot characteristic of positive cooperativity.
Such a Scatchard plot has been observed for the dimeriza-
tion ofhuman growth hormone by zinc (Cunningham et
al., 1991), but not for the dimerization ofEGF receptors
by EGF.
For our model to be consistent with the three experi-
mental observations we have considered, all the condi-
tions on the parameters that we have obtained must be
1.0
FIGURE 3 Our model predicts that if binding to a free EGF receptor
site on a dimer is independent of the state of the adjacent site, i.e.,
whether it is free or occupied (this corresponds to K, = K2), a Scatchard
plot will show curvature characteristic ofpositive cooperativity. Shown
is the predicted Scatchard plot when K1 = K2= 100 K, KXRT = 0.1. Cis
the free EGF concentration and K is the equilibrium constant for EGF
binding to a monomeric EGF receptor. The curve was calculated from
Eq. A7 and the solution to Eq. Al.
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FIGURE 5 Scatchard plots for EGF binding to membranes from cells expressing wild type or mutant EGF receptors. Plasma membrane vesicles
were isolated from mouse B82 cells expressing the indicated EGF receptor construction as described in Materials and Methods. They were
incubated to equilibrium with '25I-EGF at concentrations ranging from 0.15-40 nM, followed by separation ofbound from free ligand by filtration.
All data were corrected for nonspecific ligand binding.
cytoplasmic tail of all three receptor mutants was trun-
cated from the C end through amino acid residue 1023,
leaving receptors that lack three identified tyrosine auto-
phosphorylation sites (Downward et al., 1984) and a hy-
drophilic "hinge" region near residue 1037 (Gullick et
al., 1985). The c'1022 receptor has the truncation only,
whereas the M721c'1022 receptor is both truncated and
lacks tyrosine kinase activity due to replacement of Lys
721 in the ATP binding site of the receptor with Met
(Glenney et al., 1988). The A654M721c'1022 is an
M721c'1022 receptor in which the protein kinase C phos-
phorylation site, Thr 654, was replaced by Ala. As can be
seen in Fig. 5, Scatchard plots obtained for all of the
receptors exhibit curvature characteristic of negatively
cooperative binding. Our model predicts this qualitative
behavior only ifthe binding ofEGF to a dimer with one
EGF already bound occurs with lower affinity than the
initial binding event. If the affinities were equal, the cur-
vature of the Scatchard plot would be characteristic of
positively cooperative binding.
We also studied the equilibrium binding of EGF to
B82 cells expressing either the wild-type or a mutant re-
ceptor M72' lacking tyrosine kinase activity. The experi-
ments were done at 0°C to block internalization. EGF of
either a constant specific activity or varying specific activ-
ity (by dilution with unlabeled ligand) was used to detect
possible radiolabeling artifacts. As shown in Fig. 6, Scat-
chard plots were strongly nonlinear. Varying the specific
activity of the EGF did not significantly affect the shape
of these curves, indicating that heterogeneity in the li-
gand preparation did not contribute to curvature in the
Scatchard plot.
To see if our model could account quantitatively for
the observed curvature in the Scatchard plots we first
carried out nonlinear least squares fits of the model to
the membrane data. We did not fit the Scatchard plot
data (Bound/Free vs Bound) but rather we fit the bind-
ing data (Bound vs Free) directly. The theoretical expres-
sion we used to predict the bound EGF concentration as
a function of the free EGF concentration is given in the
Appendix (Eq. A7 with X calculated from Eq. A1). The
amount of EGF bound is a function of five parameters:
RT, the total number of receptors per vesicle; KT, the
equilibrium constant that characterizes the aggregation
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FIGURE 6 Scatchard plots for EGF binding to cells expressing wild
type or mutant EGF receptors. Mouse B82 cells expressing either wild
type (top panel) or M72' mutant receptors (bottom panel) were brought
to equilibrium at 0°C with concentrations of 1251-EGF ranging from
0.05-170 nM. The '251-EGF had either a constant specific activity of
1,600 cpm/fmol, or was systematically varied from 1.8 to 1800 cpm/
fmol by the addition of unlabeled EGF.
of free EGF receptors on membranes; and K, K1 and K2,
the three equilibrium constants that characterize respec-
tively the binding ofEGF to an unaggregated receptor, to
a receptor in a dimer with both sites free, and to a recep-
tor in a dimer with one site free and one bound. Not
surprisingly, the data do not determine the five parame-
ters uniquely. Additional experimental results on recep-
tor aggregation as a function of EGF concentration
would be needed to completely determine the parameter
set. However, our first priority is not to determine param-
eter values, but to see if the model can fit the data and
this can be done without completely determining the pa-
rameters. We found that if we fixed the value ofK and
the lumped parameter kx = KXRT and allowed the re-
maining three parameters to vary, the fitting program
converged, i.e., we could determine the three free param-
eters RT, K1 and K2 that minimized the sum of the
squared deviations of the data from the model predic-
tions. We carried out this procedure for many different
values ofKand k and found that the best fit was insensi-
tive to the values ofKand k, provided that these values
were in a particular range. IfK and k, were outside this
range we obtained poorer fits, i.e., larger sums ofsquared
deviations. To illustrate, in the case of EGF binding to
c'1022 EGF receptors on vesicles, the best fit was ob-
tained when k < l x 10'andK< lx 108 M-1. ForK
and k, in this range, the parameters K2, RT and K1k, were
approximately constant with values K2 = 3.2 X 109 M-1,
Klk, = 2.5 X 109 M- and RT = 1.9 X> 1010 receptors/,ug.
(The total number of vesicles in the sample was un-
known so we could not determine the number of recep-
tors per vesicle. Here RT is the total number of receptors
on all vesicles per ,ug ofprotein in the sample.) Note that
these parameters obey the following inequalities: K1 >
K2 > K. When these inequalities hold the model predicts
that the EGF receptor dimer concentration will be a
monotonically increasing function of the EGF concen-
tration (see Fig. 2a). Note also that for these parameters
the model predicts from Eqs. 5 and A4 that less than 9%
of EGF receptors are in dimers in the absence of EGF
and greater than 96% are in dimers at very high EGF
concentrations.
When we look at the fit of the model to the c'1022
data, Fig. 7 a, it is clear that there is a systematic error.
When Scatchard plots ofthe experiment and theoretical
prediction are compared, as in Fig. 7 b, the lack ofagree-
ment is even more striking. Fitting the Scatchard plot
data directly improves the fit, as seen in Fig. 7 c, but a
systematic error remains. Similar poor fits were obtained
for binding experiments with the other two mutants and
the wild type. Although the model as presented can give
a negatively curved Scatchard plot, it cannot account
fully for the binding data. Thus, even if binding to EGF
receptors dimers is negatively cooperative, this cannot
be the sole source of the observed curvature in the Scat-
chard plot.
There are other possible sources of curvature in the
Scatchard plot that we have not been able to control for.
For example, heterogeneity in receptor density can affect
our model. (Such heterogeneity has no effect on binding
models that ignore receptor aggregation.) Ifdifferent vesi-
cles have different surface densities of receptors, at the
same EGF concentration they will have different frac-
tions ofreceptors in monomers and dimers. Such hetero-
geneity can alter the shape of a Scatchard plot. To illus-
trate, we consider the binding ofEGF to EGF receptors
on two different populations of vesicles. The vesicles in
both populations are the same size, but have different
numbers of receptors on their surfaces. In particular, we
assume a fraction fof the vesicles have R1 receptors on
their surface and a fraction 1 -f have R2 receptors. In
Fig. 8, a and b, we see that we can achieve excellent
agreement with experiment by introducing such hetero-
geneity. Although modeling heterogeneity in cell surface
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ing experiments presented here. However, flow cytome-
try studies on B82 cells expressing the wild type EGF
receptor show a narrow distribution in receptor number.
Because these cells are relatively uniform in size, the dis-
tribution in receptor density should also be narrow. Bind-
ing studies with these cells at 0°C for both the wild type
and the receptor lacking kinase activity show curved
Scatchard plots. When we fit our theoretical model to
these binding data we obtain fits that show systematic
errors, just as occurred when the binding studies were
carried out on vesicles.
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FIGURE 7 The equilibrium binding of EGF to mutant c'1022 recep-
tors on vesicles. (a) The best fit (solid line) of the model to the binding
data (Bound versus Free). The following two parameters were held
fixed: k, = KXRT = 10-2 and K = I07 M-l. The best fit values for the
three parameters that were varied were: K, = 2.5 x 101 M-l, K2 = 3.2 x
109 M-, and RT = 1.9 x 1010 receptors/4g. A systematic difference
between the theoretical fit and the data can be seen when the residuals,
the differences between the experimental and theoretical values, are
plotted against the number of the data point are plotted (inset). (b)
Scatchard plots of the data and theoretical fit in (a). (c). The best fit of
the model to the Scatchard data (Bound/Free versus Bound). As in (a),
k, = 10-2 and K = I07 M` (held fixed). The best fit values for the three
parameters that were varied were: K, = 1.5 x 1012M , K2 = 7.1 x 109
M-1, and RT = 7.0 x 109 receptors/,gg.
receptor density as simply two populations of identically
sized vesicles with different receptor numbers is highly
artificial, the results in Fig. 8 indicate that such heteroge-
neity can account for the discrepancies between the
theory we developed in the previous section and the bind-
DISCUSSION
Scatchard plots ofEGF binding usually show curvature
associated with negatively cooperative binding. One way
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FIGURE 8 Fit ofthe equilibrium binding data for EGF binding to mu-
tant c`1022 receptors on vesicles, assuming heterogeneity in the surface
density ofreceptors. The data are the same as in Fig. 7. The model used
to fit the data assumes all vesicles are the same size, with a fraction f
having RI receptors per vesicle and (1 - f) having R2 receptors per
vesicle. (a) The following three parameters were held fixed:f= 0.999,
KJ(RI + R2) = 10-2 and K = I07 MW. The best fit values for the four
parameters that were varied were: K, = 2.7 x 1012 M-', K2 = 7.5 x 109
M-, RI = 3.2 x 1010 receptors/itg and R2 = 4.0 x 1012 receptors/,ug. No
systematic difference between the theoretical fit and the data can be
seen when the residuals, the difference between the experimental and
theoretical values, versus the number of the data point are plotted (in-
set). Comparison of the fits obtained with and without allowance for
heterogeneity in receptor density, based on the Fstatistic that would be
appropriate if the regression were linear, indicates that the improve-
ment evident in this figure is significant at p < 0.001. (b) Scatchard
plots of the data and theoretical fit in (a).
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such curvature can arise, other than by negative coopera-
tivity, is by heterogeneity in receptor binding affinities.
For this reason, much ofthe published EGF binding data
has been analyzed in terms oftwo populations of recep-
tors, one with high and one with low affinity for EGF.
However, there is no evidence for two stable populations
of EGF receptors. When genetically identical EGF re-
ceptors are expressed in cells that do not normally ex-
press EGF receptors, Scatchard plots show typical nega-
tive curvature (Glenney et al., 1988; Honegger et al.,
1988; Heisermann et al., 1990). A single EGF receptor
cannot have two binding sites with different affinities
because it has a valence of one (Weber et al., 1984). The
action of protein kinase C can alter the binding affinity
ofEGF for its receptor, and, thus, can produce heteroge-
neity in binding affinity in an initially homogeneous pop-
ulation of receptors (Cochet et al., 1984; McCaffrey et
al., 1984; Downward et al., 1985; Lin et al., 1986). How-
ever, EGF receptors on vesicles in the absence ofATP or
functioning protein kinase C show curved Scatchard
plots similar to those seen when binding studies are
carried out with cells (Downward et al., 1985; Davis,
1988). Thus, protein kinase C cannot fully explain the
nonlinear Scatchard plots seen in binding studies with
EGF receptors on cells and closed vesicles.
Because there is evidence for differential affinities of
EGF for monomeric and dimeric EGF receptors, it is
tempting to interpret results of the two-affinity Scat-
chard plot analysis as reflecting affinities of receptors in
monomers and dimers (or higher oligomers). As we have
shown, this is incorrect. To explore the relation between
receptor oligomerization and EGF receptor affinity, we
presented the simplest model that was consistent with
the known binding and aggregation properties of the
EGF receptor. This model is a generalization of the
model of Yarden and Schlessinger (1987a), modified to
allow the EGF receptor dimer to bind to a first and sec-
ond EGF with different affinities (see Fig. 1). It was first
introduced by Levitzki and Schlessinger (1974) to study
general features of ligand induced protein aggregation.
To test the model, we did EGF binding studies on mem-
brane vesicles. These experiments eliminated several
sources of heterogeneity that might lead to negatively
curved Scatchard plots. The population of EGF recep-
tors on vesicles was homogeneous with respect to pri-
mary structure because the vesicles were derived from
transfected cells expressing only one receptor genotype.
The use ofmembrane vesicles eliminated the possibility
that cytoskeletal interactions could induce a higher affin-
ity state of the EGF receptor (Wiegant et al., 1986). Us-
ing vesicles also eliminated receptor internalization and
the resulting ambiguities in interpreting binding data
(Gex-Fabry and DeLisi, 1984). Receptor mutants were
used that lacked kinase activity (Chen et al., 1989), the
major receptor autophosphorylation sites (Downward et
al., 1984), and the ability to be phosphorylated by pro-
tein kinase C (Lund et al., 1990). Heterogeneity in the
phosphorylation state of the EGF receptor was further
reduced by doing all binding studies in the absence of
ATP and protein kinase C. Heterogeneity in the EGF
preparation was shown not to contribute to curvature in
the Scatchard plot (see Fig. 6). However, we have proba-
bly not eliminated all sources of heterogeneity that affect
the affinity of EGF for its receptor. For example, some
receptors may be only partially glycosylated. Because the
state of glycosylation influences the affinity of EGF for
its receptor this could contribute to curvature in the
Scatchard plot (Slieker and Lane, 1985). EGF receptors
might interact with other proteins in the membrane
forming EGF receptor-protein complexes that have al-
tered affinities (Mayo et al., 1989; Gex-Fabry and De-
Lisi, 1986). During vesicle preparation some EGF recep-
tors might be partially denatured and bind EGF with a
reduced affinity. With the model we developed we
looked at whether the dominant source of curvature in
the Scatchard plots we obtained from membrane bind-
ing studies can be EGF induced EGF receptor aggrega-
tion.
IfEGF has one affinity for its receptor when the recep-
tor is monomeric and another when it is in an oligomer,
our model predicts that a Scatchard plot should show
positive cooperativity, something not seen forEGF bind-
ing to its receptor, but that has been seen for the dimeriza-
tion ofhuman growth hormone by zinc (Cunningham et
al., 1991). The prediction of positive cooperativity is in-
dependent of whether the high affinity state is the dimer
(Yarden and Schlessinger, 1987a) or the monomer (Bis-
was et al., 1985). We found that models postulating ag-
gregation as a source of negatively curved Scatchard
plots only work if there is negative cooperativity of the
distinct receptors in a dimer (or higher oligomer). That
is, EGF binds with higher affinity to a receptor in a dimer
with both sites free than to the second receptor in a dimer
with one site already occupied. If the affinities are the
same for the first and second binding event, the Scat-
chard plot will have positive curvature. This result is not
altered when the model is extended to include the forma-
tion of higher oligomers. We also showed that there are
further restrictions on the set of parameters consistent
with a negatively curved Scatchard plot (Eq. 7 gives that
exact condition.)
When we fit the aggregation model to the binding data
(i.e., determined parameters that gave the best least
squares fit of the predicted amounts of bound EGF to
those measured experimentally), the parameters were
consistent with negatively cooperative binding and the
predicted Scatchard plots showed characteristic curva-
ture. However, even with the parameters that gave the
best fit to the data, there was a systematic error. The
curvature in the experimental Scatchard plots was more
pronounced than could be explained by the model. In-
troducing heterogeneity in membrane receptor density
improved our fits to the data, but there is no evidence for
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such heterogeneity. Rather, flow cytometry studies on
whole B82 cells show no pronounced heterogeneity in
receptor number or cell size (data not shown), suggesting
that it is unlikely that vesicles derived from these cells
have sufficient heterogeneity in receptor density to ex-
plain the data. As we have discussed, there are other pos-
sible sources of heterogeneity that could contribute to
the observed curvature ofthe Scatchard plots. Heteroge-
neity is usually modeled in terms oftwo populations of
EGF receptors with different affinities. Note however,
that if one were to fit the binding data with just a two
population model, i.e., a model where R1 receptors have
a low affinity and R2 have a high affinity, the parameter
values one obtained from the fit would not be meaning-
ful unless there were no EGF-induced receptor aggrega-
tion. IfEGF induced receptor aggregation occurs, then it
will contribute to the curvature in the Scatchard plot and
must be accounted for.
APPENDIX
Here we develop the model more fully. Beginning with the case where
dimers are the only aggregates that form, we derive an equation for the
fraction of EGF receptors in dimers, d(C), as a function of the EGF
concentration C. We use this equation to obtain an expression for the
concentration ofEGF receptors in dimers in the absence ofEGF, Eq. 5,
and to determine parameter ranges where EGF enhances dimerization.
There are three criteria we consider for ligand-enhanced receptor aggre-
gation: d(C) is larger at very high EGF concentrations than at very low
concentrations [d(oo) > d(O)]; d(C) increases initially (d'(0) > 0); and
d(C) increases monotonically (d'(C) > 0 for all C > 0). The three
criteria correspond to different restrictions on the parameters. Next we
derive conditions for positive (negative) cooperativity ofthe Scatchard
plot. Finally, we show how the model can be extended if larger oligo-
mers form.
Ligand-enhanced receptor
dimerization
Fig. 1 summarizes our model for EGF receptor dimer formation and
EGF binding when dimers are the only aggregates that form. The six
equilibrium association constants are related by the detailed balance
Eqs. 1 and 2. Then the following conservation law holds:
RT = X(l + KC) + KXX2(l + 2K1C + K1K2C2), (Al)
where RT is the total concentration of EGF receptors on the cell sur-
face, X is the concentration of free (unbound, monomeric) EGF recep-
tors and C is the concentration ofEGF in solution.
The fraction of EGF receptors in dimers, as a function of the EGF
concentration C, is given by:
d(C)= -X(l +KC)/RT.
1 = [1 - d(O)] + KXRT[1- d(O)]2 (A3)
I = [1 - d(oo)] + KXRT(KlKJK2)[E - d(oo)]2. (A4)
(Eq. A4 depends on the observation that for the conservation law, Eq.
Al, to hold as C -d oo, XC must approach a finite limit.) Then from
Eqs. A3 and A4,
d(oo)> d(O) ¢ K1KJK2 > 1.
The other criteria we consider for ligand-enhanced dimerization in-
volve the derivative of d(C). From Eq. A2,
d-'(C) _ I KCqdC RT RT (A5)
Differentiating Eq. A 1, solving for dX/dC, substituting into Eq. A5 and
simplifying, we find that
d'(C)> 0=K1 + K1K2C> K+ KK1C
d'(O)> 0 K, >K
d'(C)> 0 for all C> 0 K, >K and K2> K.
Scatchard plot curvature
We turn now to the Scatchard plot analysis, i.e., we consider the graph
of B/C plotted as a function of B, where B is the number of ligands
bound per cell. The plot is considered to have "negative curvature,"
characteristic of negative cooperativity of ligand binding to distinct
receptors, if the curve lies below the straight line joining the two inter-
cepts (B/C at B = C = 0 and B = RT as C -. oo and B/C -O 0), and
positive curvature if the graph lies above the line. The criterion we will
use compares the initial slope ofthe Scatchard plot with the slope ofthe
straight line (-limc..o (B/C)/RT). For the Scatchard plot to lie on or
below the line we must have:
lim d(B/C) B/C <
C=o0 dB +RT
(A6)
Our aim is to derive Eq. 7, which gives conditions for Eq. A6 to hold,
guaranteeing that the Scatchard plot is not positively curved.
The number of ligands bound per cell is:
B = KCX + KXX2(K1C + K1K2C2). (A7)
The easiest way to obtain d(B/C)/dB as C -- 0 is to differentiate the
expressions for B and B/C (both obtained from Eq. A7) with respect to
C, substitute the expression for dX/dC obtained from differentiation of
Eq. (A 1), take the limits as C -* 0, and finally use the chain rule rela-
tion: d(B/C)/dB = d(B/C)/dC dB/dC. Then:
d(B/C)
lim dB
c- dB
(KXo + 2K1KXg)2
(KXo + K1KXX2)(XO + 2Kxg)
(K+K2IKXo_ (A8)
+(KXOy + K1KxX2)'
where X0 is the solution to the conservation law, Eq. Al, evaluated at
C = 0. Also from Eq. A7 we have:
(A2)
Eq. 5 for the concentration ofEGF receptors in dimers in the absence
of EGF (C = 0) follows from substitution of the unique non-negative
root X of the quadratic Eq. A into Eq. A2.
The first criterion we consider for EGF-enhanced receptor aggrega-
tion is d(oo)> d(O). We have given an intuitive argument that this
occurs when KX2 > K. or equivalently, K,K2 > K2. To derive this condi-
tion from the equations, we rewrite Eq. A in terms ofthe monomeric
receptor fraction 1 - d(C) (from Eq. A2) in the two limits of interest:
li B/C KX0 + KIKXXO
c-O RT RT
(A9)
Summing the expressions in Eqs. A8 and A9, substituting RT - XO for
KXX2 (from Eq. A at C = 0), and simplifying, we find that the inequal-
ity given by Eq. A6 holds if and only if:
(K -K)2X- K(KI - K2)(2R 2 - RTXO) < 0. (A10)
By Eq. Al, 2RT - XO = 2(XO + KXX.) - X0 = XO + 2KXX2, and hence,
Eq. A10 can be written in the form:
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K,(K,-K2) X
(K - K)2 (I1 + 2KXXo) -
Substituting for X0 the solution to Eq. Al at C = 0 yields Eq. (7),
completing the proof that the condition for the Scatchard plot not to
exhibit positive cooperativity is that the parameters satisfy Eq. (7).
Theory for higher oligomers
So far we have viewed EGF receptor aggregation as a monovalent inter-
action, i.e., ifdimers are the only aggregates that form, this means that
an EGF receptor binds to at most one other EGF receptor. The sim-
plest model where higher oligomers form treats the EGF receptor as
bivalent for other EGF receptors. Then each receptor binds at most two
others and only linear chains and rings of receptors can form. This
situation is considerably more tractable than if receptors have valence
of three or more, because then branched networks of receptors can
form. We will present the bivalent aggregation model and show that, as
in the monovalent aggregation (dimer) model, ifthe affinity ofEGF for
its receptor depends only on whether the receptor is isolated or aggre-
gated, the Scatchard plot has curvature characteristic of positive coop-
erativity.
Fig. 9 shows the binding and aggregation reactions and equilibrium
constants in the model. We are considering the case where EGF has one
equilibrium association constant K for isolated EGF receptors and an-
other, K1, for all receptors in chains oftwo or more receptors, indepen-
dent ofchain length, receptor position in a chain, and the binding state
of neighboring receptors. We assume that the formation ofclosed rings
ofEGF receptors is negligible. We allow the initial aggregation step (the
"seeding" of an aggregate) to occur with a different (perhaps lower)
equilibrium constant than the subsequent additions to the chain.
For this model, the conservation law for the concentration ofEGF
receptors in chains of all lengths is:
00
RT = (1 + KC)X + 2K,X2 z n(l + KIC)n(2K*X)n-2. (Al 1)
n=2
The most convenient form of Eq. Al 1 for the Scatchard plot calcula-
tion is:
RT = (1 + KC)X + 2KX2(1 + K1C)2
[1- 2K*(I + K1C) [1 - 2K*(1 + KIC)]2j (A )
A similar summation gives the equilibrium concentration of bound
ligand:
B = KCX + 2K,X2K1C(1 + K1C)
[1 - 2K*(l + K1C) [1 - 2K*(I + KIC)12] (A )
Note that when K* = 0, and with the appropriate identification of the
dimer formation constants (i.e., KX for monovalent aggregation is iden-
tified with 4KX in the bivalent aggregation model), Eq. Al13 reduces to
the dimer model's Eq. A7, in the special case when there is only a single
affinity for binding to a receptor in a dimer, i.e., when K1 = K2.
As before, we find the difference between the initial slope of the
Scatchard plot and the slope of the straight line joining the intercepts.
In this case we find that the difference is always positive, showing that
the Scatchard plot has the type of curvature associated with positively
cooperative binding.
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FIGURE 9 Shown are binding and aggregation reactions for one possi-
ble model where EGF receptors can form oligomers larger than dimers.
Here we assume that an EGF receptor can aggregate with at most two
other EGF receptors so that only chains or rings ofEGF receptors can
form. We neglect rings, but they can be added to the theory (e.g.,
Dembo and Goldstein, 1978). We take the equilibrium cross-linking
constant for dimer formation to be Kx and the equilibrium cross-link-
ing constant for further growth ofa chain to be K,* which may or may
not equal Kx. As before, we take K to be the equilibrium constant for
EGF to bind to a single monomeric EGF receptor. K, is the equilibrium
constant for EGF to bind to a single EGF receptor in a chain. We
assume that the binding to a free EGF receptor site in a chain is indepen-
dent ofthe state ofthe other EGF receptor sites in the chain, i.e., there is
no cooperative binding within a chain.
Received for publication 14 October 1991 and in finalform
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